Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium pentaborate supplementation in postmenopausal primary osteoporosis
IRCT20131009014957N7Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2019
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sodium pentaborate pentahydrate in involutional osteoporosis and osteopenia, sponsored by Tabriz University of Medical Sciences. Primary endpoints: Change in bone mineral density and Change in serum bone turnover markers. Started Jun 2019; status: completed.
02
Drugs
sodium pentaborate pentahydrate
03
Conditions
involutional osteoporosisosteopenia
Beyond the preview
Go deeper on IRCT20131009014957N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131009014957N7.